About

Founded

2005

Headquarters

South San Francisco, California

Industry

Biotech

Company Description

Cellworks is a leader in Precision Drug Development and Personalized Therapy Biosimulation. The Cellworks Platform predicts therapy response for individual patients and patient cohorts using a breakthrough Computational Biology Model (CBM) and biosimulation technology. Cellworks has the world’s strongest trans-disciplinary team of molecular biologists, cellular pathway modelers and software technologists working toward a common goal – attacking serious diseases to improve the lives of patients.

Quick Links

Website Jobs

Funding

Total Raised

$33 million

Valuation

Undisclosed

Significant Investors

Sequoia Capital, Artiman, UnitedHealth Group, Agilent

Company Traction

Cellworks Computational Omics Biology Model has a network of 7,000+ human genes, 30,000+ molecular species, and 100+ signaling pathways.

In 2022, Cellworks won The Challengers Innovative Business of the Year Award by Dell Technologies.

Leadership Team

Yatin Mundkur: CEO at Cellworks.

Michele Macpherson: Chief Business Officer & CFO at Cellworks. Former COO & CFO at Pinpoint Predictive.

Ansu Kumar: Chief Scientific Officer at Cellworks. Former Associate Manager R&D at Cellworks.

Brian Battey: COO at Cellworks. Former SVP at Aetna.‍

Drew Watson: Chief Biostatistician and Clinical Studies at Cellworks. Former Biostatistics & Clinical Studies at Invitae.

Press

Cellworks Blog (September 7, 2022): Cellworks Wins Dell Technologies The Challengers 2022 Innovative Business of the Year Award

Cellworks